SCHEMBL12346108

SCHEMBL12346108

CCOC(=O)C1(C)C=CC(=O)C(C)=C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
ATM Q13315 1/20 0.33
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
ADRB2 P07550 1/20 0.33
PLEC Q15149 1/20 0.33
BRD4 O60885 1/20 0.32
TSHR P16473 1/20 0.32
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.32
ALOX15 P16050 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12354407 0.80 ALDH1A1 (0.34) POLBGSK3AGSK3BALDH1A1KDM4E
SCHEMBL12346083 0.77 CYP3A4 (0.34)
SCHEMBL12346073 0.77 CYP3A4 (0.34)
SCHEMBL12346082 0.75 CYP3A4 (0.33)
SCHEMBL817577 0.70 KDM4E (0.36) POLBALDH1A1KDM4EMAPTLMNA
SCHEMBL2533046 0.68 GAA (0.35) POLBALDH1A1KDM4EMAPTLMNA
SCHEMBL817705 0.67 KDM4E (0.36) POLBALDH1A1KDM4EMAPTLMNA
SCHEMBL17113775 0.66 ALDH1A1 (0.35) POLBALDH1A1KDM4EMAPTLMNA
SCHEMBL9416759 0.63 ALDH1A1 (0.46) POLBALDH1A1ATMLMNATSHR
SCHEMBL12354409 0.62 POLB (0.37) POLBATMBRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000188-B2 Monocyclic cyanoenones and methods of use thereof TRUSTEES OF DARTMOUTH COLLEGE (US) 2015-04-07 US disclosed
US-20130274480-A1 MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-10-17 US disclosed
US-8314137-B2 Monocyclic cyanoenones and methods of use thereof TRUSTESS OF DARTMOUTH COLLEGE (US) 2012-11-20 US disclosed
US-20110196007-A1 MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196007-A1 MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF HSD17B7, HSD17B12, CYP11B2 POLB 1817/4885GSK3A 329/4885GSK3B 211/4885
US-20130274480-A1 MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF HSD17B7, HSD17B12, CYP11B2 POLB 1817/4885GSK3A 329/4885GSK3B 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.